BIO China: Business Development Panel

  • Recommend
  • Tweet
  • Print
  • Email

A 360° on China's Healthcare Capital Markets 

Thursday, October 13th, 2:00pm-2:55pm

In a time where the global financial markets are in crisis, China’s equities markets have increased more than tenfold in the last 6 years alone. As a young and evolving market, China has the unique opportunity to shape and define its presence in the global capital markets. The establishment of the ChiNext on the Shenzen Stock Exchange (SZSE) opened the door for several biopharma start-ups in China. 2010 was characterized by an IPO boom in the Chinese markets, but is this sustainable? What trends can we expect to see emerge from China’s nascent financial markets? Seasoned investment bankers will provide a 360 degree overview of the capital markets in China—past, present and future.

Panelists:

  •  Ross Hammerman,  Director, Citi Corp Healthcare Group
  •  Ling Zhang, Director, Citigroup Global Markets Asia Ltd.